» Articles » PMID: 4815080

Spontaneous and Amino Acid-stimulated Glucagon Secretion in the Immediate Postnatal Period. Relation to Glucose and Insulin

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1974 Apr 1
PMID 4815080
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The extent and significance of spontaneous glucagon secretion in the immediate postnatal period were investigated in groups of normal infants studied cross-sectionally and longitudinally. Arginine-and alanine-stimulated glucagon secretion was also studied. Plasma glucagon concentrations were correlated with prevailing glucose and insulin concentrations. The characteristic fall in blood glucose, reaching a nadir within hours of birth, was associated with a significant increase in glucagon concentration. Despite persistence of relative glucopenia, glucagon did not change appreciably between 2 and 24 h of life. A further significant elevation in glucagon concentration occurred from day 1 to day 3 of life associated with a return of glucose to euglycemic levels. In contrast to the sluggishness of pancreatic glucagon release, glucagon-like immunoreactivity rose markedly to mean levels of approximately 2,000 pg/ml after introduction of formula feeding. No significant changes in insulin levels were observed in these studies. Arginine infusion via an umbilical vein catheter into six infants within 6 h of birth elicited a brisk, almost threefold increment in glucagon concentration (from 339+/-85 to 940+/-254 pg/ml) in blood obtained from, or close to, the portal circulation. Bolus injection of alanine (1 mmol/kg) into a peripheral vein to six infants resulted in significant increments in glucagon (mean maximal, 128 pg/ml) as well as glucose and insulin. The observations suggest that spontaneous glucagon secretion may be an important factor in neonatal glucose homeostasis. Secretion seems more brisk in response to amino acid stimulation than to a falling glucose concentration.

Citing Articles

High-Throughput Sequencing Reveals Transcriptome Signature of Early Liver Development in Goat Kids.

Zhao X, Xuan R, Wang A, Li Q, Zhao Y, Du S Genes (Basel). 2022; 13(5).

PMID: 35627218 PMC: 9141777. DOI: 10.3390/genes13050833.


Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Rodgers R Physiol Rep. 2022; 10(9):e15263.

PMID: 35569125 PMC: 9107925. DOI: 10.14814/phy2.15263.


The adipokine FABP4 is a key regulator of neonatal glucose homeostasis.

Ron I, Lerner R, Rathaus M, Livne R, Ron S, Barhod E JCI Insight. 2021; 6(20).

PMID: 34676825 PMC: 8564897. DOI: 10.1172/jci.insight.138288.


Glucagon, insulin, adrenocorticotropic hormone, and cortisol in response to carbohydrates and fasting in healthy neonatal foals.

Kinsella H, Hostnik L, Rings L, Swink J, Burns T, Toribio R J Vet Intern Med. 2021; 35(1):550-559.

PMID: 33415818 PMC: 7848351. DOI: 10.1111/jvim.16024.


Insulin and glucagon levels of umbilical cord blood in appropriate for gestational age - preterm infants with or without postnatal hypoglycemia.

Park J, Bae J, Kim S, Kim C, Lee S, Kim H Ann Pediatr Endocrinol Metab. 2016; 21(2):86-91.

PMID: 27462585 PMC: 4960020. DOI: 10.6065/apem.2016.21.2.86.


References
1.
Yeung D, Oliver I . Factors affecting the premature induction of phosphopyruvate carboxylase in neonatal rat liver. Biochem J. 1968; 108(2):325-31. PMC: 1198811. DOI: 10.1042/bj1080325. View

2.
Alexander D, Britton H, COHEN N, Nixon D . Plasma concentrations on insulin, glucose, free fatty acids and ketone bodies in the foetal and newborn sheep and the response to a glucose load before and after birth. Biol Neonat. 1969; 14(3):178-93. DOI: 10.1159/000240183. View

3.
Greengard O, Dewey H . Initiation by glucagon of the premature development of tyrosine aminotransferase, serine dehydratase, and glucose-6-phosphatase in fetal rat liver. J Biol Chem. 1967; 242(12):2986-91. View

4.
FELIG P . The glucose-alanine cycle. Metabolism. 1973; 22(2):179-207. DOI: 10.1016/0026-0495(73)90269-2. View

5.
Gutman R, Fink G, Voyles N, Selawry H, PENHOS J, LEPP A . Specific biologic effects of intestinal glucagon-like materials. J Clin Invest. 1973; 52(5):1165-75. PMC: 302372. DOI: 10.1172/JCI107283. View